The nanoB2A Group

The nanoB2A Group focuses on the development of photonic and nanomechanical nanobiosensor devices of high sensitivity for label-free detection; biofunctionalization of surfaces; and the integration in lab-on-a-chip microsystems for real field diagnostics applications.

What We Do

We develop biosensors based on plasmonics, evanescent wave sensing and on nanomechanical changes, with high sensitivity and selectivity.

Bioanalytical Aplications

The Bioanalytical Applications research activities cover the detection of a wide range of molecules, of high interest in diverse fields as clinical diagnostic, environmental control, genomic and proteomic, under laboratory and real conditions and using the biosensor devices developed within the Group.

Early Detection of Diseases and Pathogens

Integration of multibiosensor arrays on Lab-on-a-chip platforms will allow the early detection of diseases and pathogens (in vitro and in-vivo).

Lab Gallery

Lab Gallery

Setup Gallery

Setup Gallery

Devices Gallery

DevicesGallery

News

Plenary Lecture at “Conferencia Nacional de Nanotecnología”

Puerto Varas (Chile),  September 10-12, 2014. Plenary Lecture of Prof. Laura Lechuga: “Nanophotonic lab-on-chip biosensors for point-of-care diagnostics: from concept to real applications”

Plenary Lecture at ” 19th Transfrontier Meeting of Sensors and Biosensors”

Next  September 25 – 26, 2014. Bellaterra (Barcelona). Prof. Laura Lechuga will deliver the lecture titled:  “Nanophotonic lab-on-chip biosensors for advanced nanodiagnostics”

Invited presentation at “Workshop on “Optical nano-fibers in Applications 2014”

International Scientific Seminars, sponsored by the Royal Society (UK), 1-2 October 2014, Chicheley Hall, London, UK. Prof. Laura lechuga will deliver the following lecture: ”Lab-on-chip nanophotonic biosensors for ultrasensitive diagnostics”

Plenary Lecture at ” 9th Ibero-American Congress on Sensors-IBERSENSOR”

15-18 October. Bogotá DC, Colombia. Prof Laura Lechuga will deliver a plenary lecture titled: Point-of-care nanobiosensors for global health diagnostics: challenges and opportunities”